CRISPR-READY IOCELLS
Live / Applied — Non-final action mailed (as of 06 Mar 2026)
What this means for you
Not registered yet, but its 31 Dec 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79428087
- Mark type
- Stylized text
- Filed
- 31 Dec 2024
- Attorney of record
- Daniel Lano
Goods and services
- Class 001 — Chemicals: Living cells for research purposes; living cells for scientific purposes; living cells for scientific and research purposes other than for medical or veterinary purposes; stem cells for research purposes; stem cells for scientific purposes; stem cells other than for medical or veterinary purposes; skeletal myocytes being cells for research purposes; cortical neurons being cells for research purposes; biological tissue cultures for research and scientific purposes; biological tissue cultures other than for medical or veterinary purposes; cultures of cell media being cells for scientific research purposes; chemical reagents for use in biotechnology, other than for medical or veterinary use, namely, chemical diagnostic reagents for industrial use; nutritive agents for processing living cells, namely, nutritive substances for processing living cells, other than for medical or veterinary purposes; semiprocessed natural proteins for manufacturing food; proteins for use in the manufacture of food products; proteins for use in manufacture using recombinant DNA technology
- Class 005 — Pharmaceuticals: Cells for medical therapeutic purposes; genetically or otherwise modified cells for medical or veterinary use; cells which are propagated, cultivated and expanded in bioreactors for medical or veterinary use; cells for the purpose of medical tissue regeneration; living cells for medical use; cells for medical use; cells for veterinary purposes; biological preparations for medical use for the treatment of cancer; diagnostic preparations for medical and/or veterinary purposes; cell preparations in the nature of cells for medical use in drug screening; cell preparations in the nature of cells for medical use in genetic testing, screening; stem cells for medical purposes; stem cells for veterinary purposes; cell growth media for growing cells for medical use, tissue culture media for cultivating tissue for medical use, cytokines being protein supplements, antibodies for medical purposes, and reagents for medical use; tissue culture media for cultivating tissue for medical use, and nutritional supplements; pharmaceutical preparations for in vitro culturing, development, maintenance, expansion, assay or manipulation of cells for the treatment of cancer; cell separation reagents for medical or veterinary use; dietary supplements; protein supplements; nutritional supplements
Owner
- Bit Bio Limited, GB
- Bit Bio Limited, GB
Prosecution history
- 02 Apr 2026 — REFUSAL PROCESSED BY IB
- 06 Mar 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 06 Mar 2026 — NON-FINAL ACTION E-MAILED
- 06 Mar 2026 — NON-FINAL ACTION WRITTEN
- 05 Mar 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 05 Mar 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 05 Mar 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 08 Jan 2026 — CHANGE OF NAME/ADDRESS REC'D FROM IB
- 03 Oct 2025 — REFUSAL PROCESSED BY IB
- 15 Sept 2025 — NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
- 15 Sept 2025 — REFUSAL PROCESSED BY MPU
- 05 Aug 2025 — NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
- 04 Aug 2025 — NON-FINAL ACTION WRITTEN
- 19 Jul 2025 — ASSIGNED TO EXAMINER
- 18 Jul 2025 — APPLICATION FILING RECEIPT MAILED